1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
617A3152F5D9FC30485256C63005B845F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/optimizing-process-integration-through-structure-and-resources?opendocument
18
19opendocument
2035.172.217.40
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services New Product Development New Product Development: Structure and Functions

Optimizing Process Integration Through Structure and Resources

DB Image

ID: 4314


Features:

Metrics, Graphics


Words: 6,702


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Portfolio management and, especially, commercialization functions are becoming more critical to company bottom-line performance as a result of numerous internal and external factors, including weak drug pipelines and intensive pharmaceutical competition. Competition in almost every therapeutic area is forcing pharmaceutical companies to conduct intensive market research and competitive intelligence activities well before a launch to ensure that the product will be sufficiently clinically differentiated and promoted. As a result, formalized structures are developed to optimize resources and improve process performance in order to build a bridge between customer needs and early drug development. This 25-page document includes discussion on developing an organizational structure to improve process effectiveness. Best practices for optimizing staffing and resources and for R&D and commercial integration are included. In addition the document examines integration of market research into commercialization and portfolio management.

Industries Profiled:
Biotech; Health Care; Pharmaceutical; Diagnostic; Manufacturing; Consumer Products; Medical Device; Automobile


Companies Profiled:
Allergan; Abbott; Bayer; Bristol-Myers Squibb; Boehringer-Ingelheim; Eli Lilly and Company; GlaxoSmithKline; General Motors; Johnson & Johnson; Novartis; Pfizer

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.